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Breaking the Barriers to Specialty Care
About this series of briefs
This series aims to highlight the urgent need for the health care sector to make progress towards achieving equity in 
outcomes from diseases that require specialty care and to identify effective solutions for the payers, providers, policy 
makers, patient organizations, and community actors who will be critical to creating change. 
The series was researched and written by FSG with the support and partnership of the Bristol-Myers Squibb Foundation. 
Findings were informed by an extensive review of clinical and field studies and more than 60 interviews with field experts, 
health care providers, and representatives from insurance companies. This work builds on the exceptional research in this field 
done by many others, referenced throughout this report. A full list of references and contributors can be found at the end of 
each brief. To access all the briefs in this series, please visit www.fsg.org/publications/breaking-barriers-specialty-care. 
About Bristol-Myers Squibb Foundation
The mission of the Bristol-Myers Squibb Foundation is to promote health equity and improve the health outcomes of 
populations disproportionately affected by serious diseases and conditions by strengthening community-based health care 
worker capacity, integrating medical care and community-based supportive services, and mobilizing communities in the 
fight against disease.
In 2015, the Bristol-Myers Squibb Foundation launched the Specialty Care for Vulnerable Populations Initiative, which aims 
to address inequities in access to and utilization of specialty care services in the United States. The goal of this national 
initiative is to catalyze sustainable improvement and expansion of specialty care service delivery to achieve more optimal and 
equitable outcomes for the people they serve who are living with cancer, cardio-vascular disease, or HIV/AIDS.
Learn more at www.bms.com/foundation. 
About FSG 
FSG is a mission-driven consulting firm supporting leaders in creating large-scale, lasting social change. Through strategy, 
evaluation, and research, we help many types of actors—individually and collectively—make progress against the world’s 
toughest problems.
FSG seeks to reimagine social change by identifying ways to maximize the impact of existing resources, amplifying the 
work of others to help advance knowledge and practice, and inspiring change agents around the world to achieve greater 
impact. With a deep commitment to health equity, FSG works with actors across sectors, including foundations, companies, 
governments, and nonprofits to accelerate and deepen population health improvements in the United States. 
As part of its nonprofit mission, FSG also directly supports learning communities, such as the Collective Impact Forum, 
Shared Value Initiative, and 100,000 Opportunities Initiative, to provide the tools and relationships that change agents need 
to be successful.
Learn more about FSG at www.fsg.org.
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Foreword
O ver the past year, FSG has partnered with the Bristol-
Myers Squibb Foundation to 
explore a tremendously significant 
yet often overlooked problem in 
today’s healthcare landscape: the 
challenge of eliminating systemic 
health disparities for patients with serious diseases 
that require specialty care. These disparities are 
pervasive and persistent, with disturbing differences 
in diagnosis, quality of treatment, and ultimately, 
mortality. 
Nearly half of all deaths in the United States are 
caused by heart disease and cancer,1 both of which 
require specialty care.  Patterns in how those diseases 
are treated undoubtedly affect life expectancy overall 
in the United States. As recent studies have shown, 
the gap in average lifespan between the rich and the 
poor in the United States has grown over time: for 
those born in 1950, the top 10% of income earners 
now live 13 years longer than the bottom 10% of 
earners—a gap that is twice as large as it was for 
those born 30 years earlier and one that equates to 
15% of the average lifespan in this country.2 
Our approach to health care contributes to these 
disparities. While the healthcare sector in the 
United States has developed remarkable advances 
in medical treatment, the structure of our delivery 
system consistently limits access to these same 
advances. Too many low-income people with life-
threatening illnesses struggle to find a specialist 
who will see them, and too many rural patients are 
forced to travel great distances to access specialty 
care. For those who can access medical care, high 
out-of-pocket costs, from co-pays to prescription 
medication, put needed care out of reach for many. 
In addition, specialty fields have historically treated 
illness as a singular problem, failing to recognize 
fully the powerful impact that social determinants of 
health can have on a patient’s ability to seek care and 
adhere to recommended treatments. Focusing system 
resources so intently on treatment and cure leaves 
fewer resources for other contributing factors and 
elements of care. And lastly, the health care delivery 
system has not consistently supported health care 
providers to assess how their own implicit biases and 
unconscious attitudes toward patients with different 
backgrounds or experiences might be compounding 
the challenges that patients experience.
Together, these dynamics have resulted in substantial 
disparities in health outcomes for those experiencing 
serious diseases, along dimensions of race and 
ethnicity, gender and sexual orientation, English 
proficiency, geography, and socio-economic status. The 
five-year survival rate for lung cancer, for example, is 
20% lower for black patients than for white patients.3 
People with lower socio-economic status have a 50% 
greater risk of developing heart disease than those 
with higher incomes and more education,4 and studies 
suggest that even for people with similar income levels, 
those who live in lower-income neighborhoods fare 
worse than their peers and are less able to adhere to 
treatment recommendations.5 The same pattern holds 
for HIV—despite accounting for only 12% of the U.S. 
population, black men and women account for 45% of 
new HIV diagnoses but are less likely to be retained in 
treatment.6 These and other disparities have persisted 
or even worsened despite the impressive advances in 
medical care that have been made in a country with 
one of the most advanced and well-resourced health 
systems in the world.
Lauren A. Smith, MD, MPH
Managing Director, FSG
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The picture, however, is not entirely bleak. A major 
benefit of the Patient Protection and Affordable Care 
Act (ACA) is the growing focus on healthcare quality 
and outcomes, and a greater understanding of the 
link between eliminating disparities and controlling 
health systems costs and improving quality. As a 
result, there is tremendous innovation across the 
healthcare system—not just to develop the next 
“blockbuster” drug, but also to create new models 
of care to improve outcomes and reduce costs, 
new methods of data collection and analysis to 
identify and address disparities, and new partnership 
models to better reach and support populations that 
experience the deepest inequity.
This represents a real moment of opportunity to 
turn these sparks of innovation into sustainable 
models that are seamlessly integrated into health 
care. However, all of this optimism will amount to 
nothing and disparities will persist or even worsen if 
we don’t work together to support and scale these 
solutions. Payers, healthcare providers and provider 
organizations, community organizations, policy-
makers at the federal and state levels, and others—
everyone has a role to play. 
Many of us who are healthcare providers, caregivers, 
and community supporters can recall the patients 
and families who are the real people whose suffering 
is obscured by statistics. And theirs are the stories 
that motivate us to harness the innovative solutions 
highlighted here to make meaningful progress 
toward equitable health for all. Our aim in this 
series of issue briefs is to raise up what is working 
to meet this aspiration, show how these solutions 
provide a return on investment, and bring often 
disparate pieces together to create a comprehensive 
common agenda for the field. With understanding, 
commitment, and collaboration, we can eliminate 
health disparities for those challenged with the most 
life-threatening diseases over the next decade. 
1   U.S. Department of Health and Human Services, National Center for Health Statistics (2016). Health, United States, 2015.  
Available at: http://www.cdc.gov/nchs/data/hus/hus15.pdf#019  
2   Tavernise, S. (2016). Disparity in Life Spans of the Rich and the Poor Is Growing. New York Times. Available at: http://www.nytimes.com/2016/02/13/health/disparity-in-life-spans-
of-the-rich-and-the-poor-is-growing.html   
3   National Cancer Institute, National Institutes of Health (2012). NCI SEER Cancer Statistics Reviews. Available at: http://seer.cancer.gov/csr/1975_2013/
4   Bikdeli B, Wayda B, Bao H, et al. (2014). Place of residence and outcomes of patients with heart failure: analysis from the telemonitoring to improve heart failure outcomes trial. 
Circulation: Cardiovascular Quality & Outcomes.  
5   Dasgupta S, Oster AM, Li J, Hall HI. (2016). Disparities in Consistent Retention in HIV Care — 11 States and the District of Columbia, 2011–2013. CDC Morbidity and Mortality 
Weekly Report.
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The challenge of health equity  
in specialty care
There is a growing imperative to address health disparities in the United States. This emerging focus is the result of a convergence of several factors: the passage of the Patient Protection and Affordable Care Act (ACA) in the 
policy arena, an ever-growing focus on quality improvement that is driving delivery and payment reform across the 
health care sector, and a broad national dialogue that is challenging the persistence of inequities across racial and 
ethnic categories, as well as socio-economic status. 
To date, research and action to reduce health disparities have been focused almost entirely on prevention and primary 
care, both critical levers in improving population health outcomes. But with the confluence of these powerful factors 
and the realities of an aging population that increasingly needs complex care, it is clear that improving health equity 
must include a focus on specialty care as well.
Indeed, disease and conditions requiring specialty care 
create the deepest disparities. Today’s specialty care 
landscape is full of incredible medical advancements—new 
immunotherapies are reducing mortality for some cancers 
by up to 32%,1  new devices and surgical practices are 
driving improvements in cardio-vascular health to prevent 
heart disease and stroke, and anti-retroviral therapies 
(ART) continue to have tremendous impact, enabling HIV 
patients to live long and healthy lives instead of facing 
what was once considered a “death sentence.” 
These advances, however, are not unequivocally and 
uniformly benefitting the populations that need them. 
The same innovations in treatment and practice that help 
extend the lives of some patients directly drive widening 
disparities between those who have access to these new 
innovations and those that do not. This pattern is evident 
in the data, which shows a widening gap between the 
lifespans of rich and poor Americans. Between 1920 
and 1950, the gap in life expectancy between the top 
and bottom 10% of earners more than doubled from 6 
to 14 years for men and 4.7 to 13 years for women.2  In 
this reality, the full promise of transformational medical 
advances is not being realized. 
How is “specialty care” defined?
Specialty care encompasses healthcare services dedicated 
to a specific branch of medicine or, in other words, all 
healthcare services not considered primary care. Typically, 
patients are referred to a specialist by a primary care 
provider for disease-specific care that requires expert 
support. Specialty care encompasses many common and 
serious disease areas, including cardiology, dermatology, 
oncology, rheumatology, immunology, psychiatry, and 
many others. For many patients, accessing and staying 
engaged in specialty care is significantly more challenging 
than in primary care given the need to engage with 
multiple providers and pursue complex and often long-
term courses of treatment. 
The data and case studies included in this paper will 
focus primarily on four disease areas: lung cancer, skin 
cancer, cardio-vascular disease (CVD), and HIV/AIDS 
(additional detail in Figure 1 on the following page). 
Together, they represent the breadth of health conditions 
handled by specialists and illustrate the diverse challenges 
and opportunities to deliver equity in specialty care. 
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Socio-economic status, race and geography remain strong determinants of health outcomes, even for acute 
medical conditions. There is robust evidence that low-income patients, rural patients, and patients belonging to 
racial or ethnic minority groups are more likely to die from cancer and other diseases than their wealthier, urban, 
and white peers (see Figure 2). Studies suggest that the elimination of racial disparities in cancer mortality 
alone would result in roughly 250,000 
fewer cancer deaths and nearly 4 million 
fewer years of life lost per year.3
These disparities in health outcomes result 
from a complex set of factors, worsened 
by broader trends of race, poverty, and the 
policy environment in the United States. 
Together, these create an accumulation of 
disparities across the care continuum for 
low-income, minority, and rural patients who 
must not only manage serious conditions 
more frequently, but also must do so without 
access to the full suite of resources and 
Figure 1. Overview of Focus Disease Areas
HIV/AIDS Lung Cancer Skin Cancer Cardovascular Disease 
and Stroke
Trends
Impact
Disease 
burden by 
geography
Midwest and Appalachia Northern states South and Midwest
• Rates of new infections 
have remained 
constant for over 10 
years
• Treatment advances 
have significantly 
reduced AIDS-related 
morbidity and 
mortality 
• Only 36% of  HIV-
positive Americans are 
in care 
• 50,000 new cases per 
year
• 1 million living with HIV  
and/or AIDS
• 220,000 new cases  
per year
• Nearly 160,000 deaths 
per year
• Incidence and mortality 
from lung cancer are 
declining, but lung 
cancer remains the 
leading cause of cancer 
deaths in America
• The average 5-year 
survival rate from lung 
cancer is only 17%
• 787,000 deaths per year
• Cardiovascular disease is the 
leading cause of death in 
America
• The most common types of 
cardiovascular disease include 
coronary heart disease, heart 
failure and stroke
• 49% of Americans have at 
least one of the three major 
heart disease risk factors—
high blood pressure, high 
LDL cholesterol, or smoking
• In some parts of the 
country, incidence 
of melanoma has 
increased 15% over the 
past 15 years
• Incidence of melanoma 
has increased for both 
men and women
• 3.5 million new cases  
per year
• 73,000 of which are 
melanoma
Top 10 state - total population Top 10 state - incidence Top 10 state - incidence & population
South
Figure 2. Disparities in Cancer Outcomes by Population Group
Socioeconomic 
Status
Race and Ethnicity Rural/Urban 
Continuum
Bottom 
Decile
4th-7th 
Decile
Top 
Decile
Black White Hispanic Rural Small 
Metro
Large 
Metro
220
202
184
171168
119
193 189 179
Age adjusted all cause cancer mortality, per 100,000 population
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support necessary for recovery. If these disparities are left unaddressed, each new advance 
in medical technology will help extend the lives of a select few, but will also result in a 
growing number of preventable and premature deaths for many others. 
The battle against lung cancer casts these disparities in sharp relief. Lung cancer is one of 
the leading causes of death in the United States and the leading cause of cancer deaths, 
resulting in nearly 160,000 deaths in 2015—more than 400 deaths every day. Not only is 
it one of the most common cancers, it is also among the deadliest. Even when they are 
diagnosed at the earliest stages, lung cancer patients have only a 50% chance of five-year 
survival. If diagnosed in Stage III, five-year survival rates plummet to 14%. They are just 1% 
for those diagnosed in Stage IV (see Figure 4 on the next page). 4
For a disease this pernicious, new immunotherapies can truly save lives, but only if the populations that currently 
experience the worst outcomes have access to them. For example, the five-year survival rate for lung cancer is 
20% lower for black men than white men.5 Reducing such drastic differences will require far more than traditional 
pharmaceutical company patient assistance programs or even the expansion of insurance coverage under the Patient 
Protection and Affordable Care Act (ACA). Addressing this need and eliminating these disparities will require new 
models of engaging and supporting patients across the care continuum, from initial risk factors for disease, to 
screening and diagnosis, through to follow-up care and treatment (see Figure 3).  
“ Of all the forms of 
inequality, injustice 
in health care is the 
most shocking and 
inhumane.” 
—Martin Luther King, Jr. 
(1966) 
Figure 3. Disparities in Lung Cancer Throughout the Patient Pathway
Black smokers are  
20% more likely to have 
lung cancer than white 
Americans who smoke 
the same amount  
Black Americans are far 
more likely to have a  
late-stage diagnosis  
than white Americans
Patients on Medicaid 
wait 5 times longer 
to see an oncologist 
than patients on 
private insurance.
Black Americans are 
20-70% less likely 
to receive life-saving 
treatment than white 
Americans and are 30% 
less likely to be referred 
to smoking cessation
Patients from communities 
with household incomes 
below $30K are  
25% likely to die within  
30 days of lung surgery 
than wealthier patients 
RISK FACTORS  
FOR DISEASE
TIMELY SCREENING 
AND DIAGNOSIS
FOLLOW-UP WITH 
SPECIALIST
HIGH-QUALITY CARE
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“ It is time to refocus, 
reinforce, and repeat 
the message that health 
disparities exist and that 
health equity benefits 
everyone.” 
 —KathLeen g. SebeLiuS, 
ForMer Secretary, 
u.S. heaLth & huMan ServiceS
Figure 4. The Health Outcome and Financial Costs of Late Diagnosis in Lung Cancer
An opportune moment for  
sector-wide action
W ith mounting evidence of these disparities, there is a growing conversation around health equity. Health equity is “achieved when 
everyone, regardless of race, neighborhood, or financial status, has the 
opportunity for health—physical, mental, economic, and social well-being.”6 
Spurred by the 2002 landmark report from the Institute of Medicine (IOM), 
“Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care,” 
the sector is increasingly recognizing the importance of health equity to drive 
improvements in health outcomes for patients. The 2011 U.S. Department of 
Health and Human Services Action Plan to Reduce Racial and Ethnic Disparities: 
A Nation Free of Disparities in Health and Health Care illustrates this growing 
focus.
Implementation of the ACA in 2014 inaugurated the next stage in this conversation. With a goal of universal 
health insurance coverage, the ACA lays the groundwork to realize affordable, accessible, high-quality health 
care for all. Payers and providers are also increasingly recognizing the need to address equity in specialty 
care head-on. For example, the Dana Farber Cancer Institute in Boston has established a Cancer Care Equity 
Program (CCEP). Private insurer UnitedHealth Group created the Health Equity Services department in 2010 
Mean California Medicare   
Spending in First Year of Diagnosis
Stage I 5 out of 10
3 out of 10
1 out of 10
1 out of 100
$60,038
$73,509
$84,726
$90,166
Stage II
Stage III
Stage IV
Patient Likelihood of 5-Year Survival
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“ With the advent of accountable care and 
other new models, if we’re well organized, 
we can do more to mitigate disparities 
because we are looking at whether patients 
have a well-functioning system of care as 
opposed to specific pieces of the care they 
need.”
—MedicaL director, 
MaJor private heaLth inSurance coMpany
to consult with business units to support the development and 
implementation of solutions to drive improved health equity 
among their members. In addition, professional associations 
like the American Society of Clinical Oncology (ASCO) and 
the American Association for Cancer Research (AACR) have 
introduced specific initiatives focused on disparities, including 
the Health Disparity Committee at ASCO and the annual AACR 
Conference on the Science of Cancer Health Disparities in 
Racial and Ethnic Minorities and the Medically Underserved. 
For the health system, addressing these disparities is not only 
a moral but also a financial imperative. Researchers estimate 
that eliminating racial disparities across all cancers would 
save $2.3 billion in direct care costs, and $500 million in productivity costs.7  Studies have also shown that 
late diagnosis of cancer is directly related to these costs of treatment. In lung cancer, for example, early diagnosis 
and treatment saves an average of 30% of treatment costs in the first year and up to 50% of costs over a seven-
year period (see Figure 4).8 In this case, the cost of treatment and patient likelihood of survival are also closely 
linked.
Despite its importance for patients, payers, providers, and policy makers, improving specialty care provision 
for low-income, rural, and minority patients has historically been addressed through the efforts of individual 
organizations, piecing together grant funding from public and private sources. Today’s health care landscape, 
however, provides a strong enabling environment to tackle disparities along the care continuum comprehensively 
and sustainably. Five current trends make this an opportune moment to develop sustainable, scalable solutions 
for equity in specialty care.
1  Expanded insurance coverage under the Patient Protection and Affordable Care Act (ACA). The ACA has driven the greatest gains in health insurance coverage in decades, enabling more people 
to seek affordable care and health care providers to better serve more people.9  Since the passage of 
the ACA, more than 20 million people have gained insurance coverage through Medicaid expansion, 
procuring individual plans on state or federal exchanges, or as young adults newly able to remain on 
their parents’ plans until age 26.10 These changes have reduced the uninsured rate from 20.3% in 
2013 to 11.9% by the end of 2015,11  bringing millions of low-income patients, many of whom had 
previously relied on charity care, into the formal health care system. This makes equity more important 
for specialty care providers in two ways: it increases the patient load, particularly of low-income patients, 
that specialists will need to manage, and it enables payers and providers to move beyond “charity care” 
programs to develop sustainable solutions to improving equitable care and outcomes for previously 
underserved populations.12, 13
10
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2 Movement toward value-based payment models. Recognizing that health outcomes and 
health costs can be closely intertwined, insurance 
providers are increasingly experimenting with 
new payment models that link reimbursement to 
improved quality of care and health outcomes rather 
than the volume of services provided.14  The ACA 
itself is accelerating this shift by supporting uptake of 
models such as capitation, episode-based payment, 
and accountable care—which reimburse providers 
on the basis of the number of people treated, the 
number and type of medical episodes treated, and 
health care quality, respectively.15 This renewed focus 
on results necessitates attention to health equity and to improving health outcomes for those who 
have historically been left behind. Enabling payers and providers to invest in solutions to drive patient 
outcomes that have historically fallen outside of fee-for-service payments, these new models show 
potential to create the necessary financing structures to address health disparities in specialty care. 
3 Investment in new care delivery models. Payment reform has also accelerated innovation around health care delivery. The Centers for Medicare & Medicaid Services (CMS) are supporting several 
large programs to fund experimentation with new payment and delivery models that could improve 
health outcomes while reducing costs. These include the Health Care Innovation Awards16 and the 
State Innovation Models program,17 which have disbursed almost $2 billion since 2012.18  In addition, 
a growing number of patients are being served through integrated delivery networks, which bring 
together hospitals, primary care providers, clinics and health insurance providers. Together, these shifts 
have enabled innovations like patient-centered medical homes, which have been shown to reduce 
health disparities.19
4 Greater collaboration between communities and the health care system. This increased focus on health outcomes is pushing payers and providers to look outside of their own doors toward the 
social determinants of health. For example, recognizing housing insecurity as a key source of stress and 
as a contributor to health disparities for low-income patients, CMS announced in 2015 that Medicaid 
funding could be used to support housing services for chronically homeless individuals.20  CMS is 
broadening this work through the “Accountable Health Communities Model” initiative. Established 
in January 2016, the initiative is a five-year, $157 million program to test how helping patients access 
community-based social services related to their health needs will improve quality and affordability in 
Medicaid and Medicare.21  With these initiatives, CMS is picking-up a growing practice of providers to 
“ We’ve become much more strategic about 
building community partnerships. We don’t 
just show up—we engage our partners, 
and their partners. We sit down and share 
our knowledge and engage in a dialogue 
of how to move forward. And I’ve seen our 
grassroots efforts have significant impact 
and added value.”
—Karen burnS White 
dana-Farber/harvard cancer center
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establish community-clinic collaborations to better meet the needs of their patients, while leveraging 
the core competencies of each partner organization. A 2013 Robert Wood Johnson Foundation survey 
of health and community development practitioners highlighted numerous examples of community-
clinic collaborations to address issues including physical activity, access to health care, and access to 
healthy food.22  These collaborations are essential to removing barriers and ensuring that everyone can 
benefit from specialty care.
5 A national conversation on equity. These changes are taking place within the context of a 
broad, national conversation on racial, economic, 
and gender equity in the United States. This 
context is an essential factor in efforts to address 
health disparities. It serves to raise awareness and 
understanding of health disparities, highlight the 
need for solutions, and heighten the sense of 
urgency for action. Over the past year, the national 
conversation has manifested in the health care field 
with the emergence of groups like White Coats for 
Black Lives, a student-led initiative whose mission 
is “to counteract systemic and interpersonal racism 
and its effects on the practice of medicine and the 
health of our patients.” Associations for medical 
professionals are also increasingly integrating 
equity as a primary focus of their work, illustrated 
by Equity of Care, an organization established by 
the Association of Academic Medical Centers, the 
American Hospital Association, and others, as a call to action for health care providers to make progress 
on three pillars of equity: (1) the collection and use of race, ethnicity, and language preference data; 
(2) increasing the staff’s cultural competence capabilities; and (3) increasing diversity in governance and 
leadership. To date, nearly 1,000 hospitals have signed the “#123 For Equity” pledge.
These five trends will enable greater adoption of solutions for health equity—but much of what needs to 
change is yet to come. The current health care landscape presents both significant remaining disparities and 
emerging solutions to address them. These solutions are summarized in the next section, and explored in more 
detail in the other briefs in this series.
“ New people coming into the health 
system with insurance are less likely to 
speak English, less likely to have a college 
education, and more likely to be part 
of a minority group. So we all need to 
think about it—are we really prepared 
to take care of these populations? 
Health organizations are starting to 
understand that and it’s driving growing 
activity to address health disparities. And 
requirements from CMS to track and 
report data and desire to control costs are 
all contributing to the momentum.”
—aSWita tan-Mcgrory, 
the diSparitieS SoLutionS center at 
MaSSachuSettS generaL hoSpitaL
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A number of solutions are emerging to improve equity in specialty care. These efforts originate from various points in the specialty care system—some initiated by provider institutions, some led by community 
organizations or local governments, and others introduced by public or private payers. Despite these varied 
origins, the most successful efforts consistently integrate and leverage the core competencies of multiple actors 
in the health system to effectively support and engage patients and develop sustainable financing mechanisms 
that enable programs to last beyond an initial pilot phase.
Together, these solutions address the diverse factors that drive health disparities both within and outside of 
the health care system. In order to create true health equity—across socio-economic status, race, ethnicity, and 
geography—all of these factors will need to be addressed. These solutions fall into three categories (see Figure 5).
The sections below provide additional detail on each area, highlighting the current equity challenge and 
emerging solutions. The other briefs in this series provide a deeper look at each area, including case studies of 
effective initiatives, evidence of impact on health outcomes and health systems costs, and recommendations 
for broader adoption of these solutions.
Emerging health equity solutions  
in specialty care
Ensuring High-
Quality Care
Helping 
Patients
Engage 
in Care
Increasing
Specialty
Care 
Availability
EQUITABLE
HEALTH
OUTCOMES
Figure 5. What is Needed to Improve Equity in Specialty Care
Increasing Specialty Care Availability 
to better enable access to specialty care  
for rural and low-income populations. 
For more analysis, examples, and  
solutions, see Brief 2: Increasing  
Specialty Care Availability  
Ensuring High-Quality Care 
to better meet the needs of low-income and 
minority patients engaged in specialty care. 
For more analysis, examples, and solutions, 
see Brief 3: Ensuring High Quality 
Specialty Care  
Helping Patients Engage in Care 
by addressing the social factors that impede 
patients’ ability to promote and protect their 
own health, engage in care, and adhere to 
treatment. 
For more analysis, examples and solutions, 
see Brief 4: Helping Patients Engage in 
Specialty Care 
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One of the largest drivers of inequity in specialty care is access. Specialist availability is limited, 
particularly for low-income and rural patients. Many 
specialists are unwilling to see uninsured patients and 
are even reluctant to see patients on Medicaid. This 
stems both from inadequate reimbursement—a 2012 
study found that Medicaid reimbursed 66 cents for every 
dollar reimbursed by Medicare—and from the additional 
administrative burden posed by caring for low-income 
patients, who often require more eligibility paperwork 
and are more likely to miss appointments.23, 24  As a 
result of limited specialist availability, patients requiring 
specialty care face significant delays—a 2013 study by 
the Ralph Lauren Cancer Center of stage IV lung cancer 
patients showed that patients with commercial 
insurance wait an average of 10 days to see an 
oncologist, while Medicaid patients typically wait 
up to 53 days for the same appointment.25   This 
disparity is even more problematic when considering 
that the average life expectancy for untreated stage IV 
lung cancer patients is just 90 days.26  
For patients in rural areas, the access problem is different. Rural areas are home to 20% of the U.S. population 
but few specialists—for example, just 3% of medical oncologists practice in rural areas. These circumstances 
force rural patients to travel significant distances to see specialist providers in urban centers, which is 
particularly challenging for those undergoing daily or weekly treatments for cancer and other diseases (e.g., 
for chemotherapy, radiation, or dialysis). According to the Community Transportation Association (CTA), 
approximately 3.6 million Americans miss or delay 
medical care because of transportation reasons.27 
Numerous studies have shown that this holds even for 
critical cancer treatments, including a 2012 study of 
colorectal cancer patients in Virginia in which 19% of 
cancer patients surveyed struggled with transportation 
to treatment. While every state Medicaid program 
offers some form of reimbursement, subsidy, or service 
for non-emergency medical transportation, many 
states require a formal request and prior approval, 
often a minimum of 72 hours in advance.28    
Increasing Specialty Care Availability 
“ One of the great frustrations articulated by 
every health center clinician is that when 
their patients need care that goes beyond 
their skills, such as specialty care, they 
struggle greatly to find someone who will 
accept their patients – even those with some 
kind of marketplace coverage or Medicaid.”
—dan haWKinS, 
nationaL aSSociation oF coMMunity heaLth centerS
 
Snapshot: Increasing Specialty Care Availability
Target Patient Populations
• Low-income patients
• Rural patients  
Relevant Drivers of Inequity in Specialty Care
• Provider refusal of uninsured or Medicaid patients
• Limited availability of specialists in rural areas
• Complex or ad hoc referral processes between primary  
and specialty care, especially for uninsured patients 
Health Equity Solutions
• Telemedicine and telementoring
• Development of primary care capacity to provide  
appropriate specialty care
• Coordinated specialist networks that streamline charity care
14
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Emerging Solutions: Increasing Specialty Care  
Availability
Recognizing that the status quo is insufficient, the sector is increasingly looking at solutions that will enable 
greater access to specialty care among low-income and rural populations. Community organizations like the 
Project Access partnerships in communities across the country, are establishing coordinated networks of 
specialists across health care providers in a local area to improve access to care for the un- or under-insured 
and to streamline provision of care for providers. In addition, initiatives like Project ECHO are increasingly 
leveraging new technologies that allow specialists and super-specialists to use telemedicine to teach and 
support community-based and primary care physicians to provide some specialist services. These solutions 
leverage existing health infrastructure and technology to enable “task shifting” between different cadres of 
health care workers to provide greater specialty care access to hard-to-reach populations.  
Learn more about these solutions in Brief 2: Increasing Specialty Care Availability.
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Increasing the availability of specialty care services 
is just one part of the solution. Ensuring high-
quality care is equally important to delivering health 
outcomes and reducing health disparities. Health 
care in the United States, especially specialty care, is 
often delivered through a two-tiered system. Those 
who can afford it get treatment at high-quality 
academic specialty medical centers, like the National 
Cancer Institute-designated Comprehensive Center 
Centers or the Cleveland or Mayo Clinics. For those 
who cannot afford this level of care, however, there 
is a different system of safety-net facilities and free 
clinics. These differences result in real disparities in 
health outcomes—a 2013 study comparing results 
for colorectal cancer patients across a public safety-
net hospital and a private comprehensive cancer 
center found that three-year overall survival and 
relapse-free survival rates were significantly 
higher for patients at the private cancer center 
than for those who received care at the safety-
net facility. The study also found that patients at 
the safety-net facility were less likely to complete full 
courses of chemotherapy and were more likely to 
experience delays and service defects.29     
These differences extend to the broader care environment, which is not welcoming or comfortable for many 
low-income patients. Safety-net health care facilities in New York City, for example, often have armed guards 
in waiting rooms, glass partitions, and overwhelmed front office staff, all of which send implicit messages to 
patients that they are neither trusted nor welcome.30    For patients who do not speak fluent English, the health 
care environment is even more challenging.
Unfortunately, providers themselves often compound these challenges. Research increasingly suggests that 
implicit or unconscious biases can influence providers’ perceptions of low-income or minority patients. These 
biases affect their manner with patients as well as their decision-making. A recent study of a hospital in 
Pennsylvania found that health care workers, including physicians and nurses, use fewer supportive social 
cues such as standing next to a patient’s bedside or holding a patient’s hand with their black patients relative 
Ensuring High-Quality Specialty Care
Snapshot: Ensuring High-Qualty Specialty Care 
Target Patient Populations
• Low-income patients
• Minority patients
• Low-English proficiency patients 
Relevant Drivers of Inequity in Specialty Care
• Cultural and linguistic challenges 
• Implicit biases among providers that result in  
sub-optimal treatment recommendations and limited 
choice for patients
• Lack of patient empowerment and confidence with  
medical decision-making 
Health Equity Solutions
• Culturally-competent care and language services
• Efforts to address implicit bias among health care  
workers
• Quality improvement approaches to target disparities
16
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Emerging Solutions: Ensuring High-Quality  
Specialty Care
To improve the quality of treatment that low-income and minority patients receive, there is growing understanding 
and practice amongst payers and providers, such as Kaiser Permanente in California and HealthPartners in 
Minnesota of culturally-competent care for patients. Leading organizations are also harnessing the tools of 
quality improvement to identify disparities and innovate to address them. In addition, a diverse set of actors, 
including medical schools such as University of California, San Francisco (UCSF), patient advocacy organizations, 
and health care providers are exploring different methods of addressing and mitigating the effects of implicit 
bias among health care workers, including building the diversity of their own staff and leadership.  
Learn more about these solutions in Brief 3: Ensuring High-Quality Specialty Care.
to their white patients.31   In some cases, these biases influence 
the courses of treatment that doctors recommend. For example, 
a large study of Medicare patients from 1991 to 2002 showed 
provider bias, alongside patient attitudes, as a significant 
contributor to disparities between patients of different races. 
In the study, black early-stage, non-small-cell lung cancer 
patients were 37% less likely to receive surgery and 42% 
less likely to receive chemotherapy than their white peers. 
For late-stage cancer, this rose to a 57% disparity in treatment 
received.32
For patients, these factors culminate in feelings of disempowerment 
and dissatisfaction with their care that eventually affect their 
retention in care and health outcomes. Multiple studies have 
demonstrated strong links between patient trust and health 
outcomes from specialty care: for example, a 2012 study of 175 patients at urban HIV clinics found that 
patients with trust in their physicians were more likely to adhere to ARV regimens.33 Similar results have 
been found across diseases—a recent 2014 study of black women also cited health care worker bias as a factor in 
delayed cervical cancer screening and disparities in follow-up and treatment between black and white patients.34
“ At many of the hospitals in impoverished 
neighborhoods, not going in for 
screenings or follow-up care is a very sane 
decision. They can be dirty and crowded, 
you might be met with security guards or 
hospital police, and you are likely to wait 
for hours. Who among us would go back? 
We essentially have a two-tiered health 
care system—and we need to recognize 
that.”
—gina viLLani, Md, 
raLph Lauren center For cancer care
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These improvements to specialty care availability and 
quality are essential—but insufficient. In order to 
truly address disparities, specialty care providers and 
other actors in the system must support patients to 
engage in care. This will require the health system to 
look beyond its traditional boundaries, towards what 
are now understood to be the “social determinants 
of health.”
The most commonly recognized challenge for low-
income patients in specialty care is the cost of specialty 
care treatment and medicines. The introduction 
of even small co-pays (or “cost sharing” under 
Medicare) for screenings can reduce uptake—one 
study showed that rates of mammography screening 
decreased by 12.3% in low-income populations after 
the introduction of a co-pay, more than three times 
the impact in higher income populations.35  This 
same dynamic holds for drug coverage as well. The 
new generation of Hepatitis C drugs, for example, is 
highly effective in curing the disease—but prices for 
the drugs are so high that few state Medicaid plans 
provide full coverage for them. In thirty-four states, 
patients are denied access to the cure until they show 
signs of existing liver damage.36  
The barriers facing specialty care patients are not solely financial. For some, inflexible work hours, lack of 
childcare, and transportation challenges can make it difficult for patients to seek and stay engaged in care. 
For others, socio-economic factors can impede their ability to adhere to treatment recommendations. Patients 
with cardio-vascular disease, for example, are recommended a “heart healthy diet,” comprised primarily of 
fresh fruits and vegetables, whole grains, and lean proteins like fish. Yet patients who live in low-income 
neighborhoods often lack easy access to high-quality grocery stores, relying instead on local convenience 
stores and bodegas for food. Patients who live in these areas, known as “food deserts,” are at higher-risk for 
contracting heart disease and are less likely to adhere to a physician’s dietary restrictions. Research has shown 
that adherence to dietary recommendations is directly related to proximity to grocery stores for low-income 
populations.37  As a result, studies show that heart failure patients living in low-income neighborhoods are 10% 
more likely to be readmitted to the hospital than those living in wealthier neighborhoods.
Helping Patients Engage in Specialty Care
Snapshot: Helping Patients Engage in  
Specialty Care
Target Patient Populations
• Low-income patients
• Minority patients 
Relevant Drivers of Inequity in Specialty Care
• Disease awareness and health literacy 
• Environmental factors (e.g., housing, food security, 
childcare)
• Stigma and/or distrust of the healthcare system
• Financial burden of disease
• Psychological burden of disease 
Health Equity Solutions
• Community outreach to engage patients
• Patient navigation
• Patient support services
18
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Social attitudes and stigma can also play a role. Evidence, for 
example, suggests that people are reluctant to seek HIV testing 
in health care settings, often listing a different service as the 
primary reason for attending a health care appointment.38 
For some with cancer, a sense of “fatalism” directs patients 
to opt-out of treatments with life-saving potential. A related 
concern is patients’ attitudes towards the health care system. In 
particular, African Americans have a well-documented distrust 
for the health care system and medical research, rooted in the 
history of events such as the Tuskegee Syphilis Experiment, research conducted from 1932 – 1972 by the U.S. 
Public Health Service (PHS) and Centers for Disease Control (CDC) that studied but knowingly denied curative 
treatment to 600 African American sharecroppers with syphilis, including failure to inform the patients of their 
diagnosis, in order to observe the progression of the disease. The participants were provided free health care 
and meals in exchange for their uninformed participation, and were often lied to about the nature of diagnostic 
tests and other activities. Current perceptions of differences in care quality due to race perpetuate this distrust.39 
In addition, for specialty care patients, navigating the care continuum is an immensely difficult challenge. A 
patient with lung cancer, for example, undergoes multiple tests in the diagnosis phase followed by months of 
treatment that can include radiation, chemotherapy and surgery. These patients are required to navigate an 
assortment of health insurance, charity care and pharmaceutical company patient assistance programs to cover 
the costs of the tests and treatments. While more low-income patients have health insurance coverage under 
the ACA, this is driving a growing need for patients to have health insurance literacy. Surveys of the newly 
insured population suggest that many patients are on plans with narrow networks and that patients have 
confusion about which doctors are in their new networks. This has led to continued difficulty for patients and 
additional administrative burden for specialists through the referral process.40, 41  Language and cultural barriers 
between patients and providers can exacerbate this problem.
Given these challenges, the results are not surprising: of the 1.2 million people in the US living with HIV, 
65% are diagnosed but not in consistent care.42   Studies of cancer patients show similar patterns, with the 
evidence suggesting that low-income and minority patients have lower cancer screening rates and experience 
longer lags between diagnosis and follow-up across cancer types—factors that are directly responsible for 
disparities in morbidity and mortality outcomes.43
“ It has been said that the most important 
factor in understanding someone’s health 
status is their ZIP code. Your circumstances 
impact your overall health and your ability 
to access adequate health care.”
—deborah c. enoS, 
ForMer ceo, neighborhood heaLth pLan
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Emerging Solutions: Helping Patients Engage in  
Specialty Care
Seeking to improve health equity and control costs, specialty providers like Cedars-Sinai Heart Institute and the 
Dana Farber Cancer Center, are increasingly conducting community outreach to engage patients, through 
community health workers or mobile units, to reach patients who would not otherwise engage with the 
health care system and introducing patient navigation to support patient retention in care. Simultaneously, 
community and patient support organizations, like CancerCare and Cancer Support Community, are aligning 
with the health care system to support patients with patient support services such as psychosocial counseling, 
transportation and housing. Insurance providers, such as UnitedHealth Group, are also recognizing the value of 
these activities and starting to identify them as reimbursable expenses in support of patient outcomes.
Learn more about these solutions in Brief 4: Helping Patients Engage in Specialty Care.
This series of five briefs explores these solutions and others, to highlight what is working to deliver improved 
health access and outcomes, identify opportunities to make these solutions a core part of the health care 
system, and inform evolving federal and state policy dialogues. Addressing these issues will require coordinated 
activity across communities and all levels of the health care system (read more about the need for institutional 
and sector action in Brief 5: Call to Action for a System-wide Focus on Equity). Our hope is that this 
comprehensive portrait of current dynamics and opportunities for improvement will provide a common agenda 
for the progress that we so desperately need.
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